{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:51:46Z","timestamp":1790621506787,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.01498","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T23:46:13Z","timestamp":1578959173000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["N6-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression"],"prefix":"10.3389","volume":"9","author":[{"given":"Giovanna","family":"Navarra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Crescenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Longobardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Gazzerro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pastorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pentimalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Laezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Bifulco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.trecan.2015.10.009","article-title":"Glioblastoma: defining tumor niches","volume":"1","author":"Hambardzumyan","year":"2015","journal-title":"Trends Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.mayocp.2017.01.010","article-title":"Treatment of glioma in the 21st century: an exciting decade of postsurgical treatment advances in the molecular era. Mayo Clin Proc","volume":"92","author":"Uhm","year":"2017"},{"key":"B4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1158\/1078-0432.CCR-07-1856","article-title":"In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide","volume":"14","author":"Kil","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11060-017-2427-7","article-title":"GBM radiosensitizers: dead in the water\u2026or just the beginning?","volume":"134","author":"Bindra","year":"2017","journal-title":"J Neurooncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/187152008783497028","article-title":"Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug","volume":"8","author":"Bifulco","year":"2008","journal-title":"Anticancer Agents Med Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1096\/fj.13-238238","article-title":"Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation","volume":"28","author":"Pisanti","year":"2014","journal-title":"FASEB J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1096\/fj.05-4044lsf","article-title":"N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation","volume":"20","author":"Laezza","year":"2006","journal-title":"FASEB J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1189\/jlb.0413190","article-title":"N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation","volume":"94","author":"Ciaglia","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"7798","DOI":"10.1021\/jm500869x","article-title":"Structural evidence of N6-isopentenyladenosine as a new ligand of farnesyl pyrophosphate synthase","volume":"57","author":"Scrima","year":"2014","journal-title":"J Med Chem"},{"key":"B11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/ijc.30505","article-title":"Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor","volume":"140","author":"Ciaglia","year":"2017","journal-title":"Int J Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/bjc.2014.385","article-title":"Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation","volume":"111","author":"Souchek","year":"2014","journal-title":"Br J Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"70869","DOI":"10.18632\/oncotarget.12281","article-title":"Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14123","DOI":"10.1038\/s41598-017-14495-6","article-title":"Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in glioblastoma","volume":"7","author":"Abate","year":"2017","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) methods","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ijc.31036","article-title":"Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines","volume":"142","author":"Ciaglia","year":"2018","journal-title":"Int J Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/35075107","article-title":"Initiation of a G2\/M checkpoint after ultraviolet radiation requires p38 kinase","volume":"411","author":"Bulavin","year":"2001","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/em.21944","article-title":"DNA damage foci: meaning and significance","volume":"56","author":"Rothkamm","year":"2015","journal-title":"Environ Mol Mutagen."},{"key":"B21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrc2342","article-title":"Nat Rev Cancer.","volume":"8","author":"Helleday","year":"2008"},{"key":"B22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ctrv.2014.10.006","article-title":"Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51","volume":"41","author":"Ward","year":"2015","journal-title":"Cancer Treat Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1158\/1078-0432.CCR-17-2768","article-title":"STAT5A\/B blockade sensitizes prostate cancer to radiation through inhibition of RAD51 and DNA repair","volume":"24","author":"Maranto","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B24","first-page":"589","article-title":"Characterisation of the promoter region of the human DNA-repair gene Rad51","volume":"26","author":"Hasselbach","year":"2005","journal-title":"Eur J Gynaecol Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3978\/j.issn.2305-5839.2016.01.25","article-title":"Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma","volume":"4","author":"Khosla","year":"2016","journal-title":"Ann Transl Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"012716","DOI":"10.1101\/cshperspect.a012716","article-title":"DNA damage sensing by the ATM and ATR kinases","volume":"5","author":"Mar\u00e9chal","year":"2013","journal-title":"Cold Spring HarbPerspect Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1021\/jm201173g","article-title":"Inhibition of homologous recombination in human cells by targeting RAD51 recombinase","volume":"55","author":"Huang","year":"2012","journal-title":"J. Med Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e770","DOI":"10.1259\/bjr\/83827377","article-title":"Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?","volume":"1017","author":"Hingorani","year":"2012","journal-title":"Br J Radio."},{"key":"B29","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ijrobp.2004.03.005","article-title":"Role of cell cycle in mediating sensitivity to radiotherapy","volume":"59","author":"Pawlik","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B30","doi-asserted-by":"publisher","first-page":"24638","DOI":"10.1074\/jbc.M101291200","article-title":"Caspase-3-mediated cleavage of the NF-kappa B subunit p65 at the NH2 terminus potentiates naphthoquinone analog-induced apoptosis","volume":"276","author":"Kang","year":"2001","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/neuonc\/nou058","article-title":"Role of AKT signaling in DNA repair and clinical response to cancer therapy","volume":"16","author":"Liu","year":"2014","journal-title":"Neuro Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"8352","DOI":"10.1158\/0008-5472.CAN-06-0533","article-title":"Tumor cell radiosensitivity is a major determinant of tumor response to radiation","volume":"66","author":"Gerweck","year":"2006","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","article-title":"The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer","volume":"108","author":"Smith","year":"2010","journal-title":"Adv Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.canlet.2014.09.043","article-title":"BRCA1, FANCD2 and Chk1 are potential molecular targets for the modulation of a radiation-induced DNA damage response in bystander cells","volume":"356","author":"Burdak-Rothkamm","year":"2015","journal-title":"Cancer Lett"},{"key":"B35","doi-asserted-by":"publisher","first-page":"11384","DOI":"10.1158\/0008-5472.CAN-05-2156","article-title":"BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis","volume":"65","author":"Cousineau","year":"2005","journal-title":"Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/1947601913485414","article-title":"Mitogen-activated protein kinases and their role in radiation response","volume":"4","author":"Munshi","year":"2013","journal-title":"Genes Cancer."},{"key":"B37","first-page":"219","article-title":"Elevated levels of Rad51 recombination protein in tumor cells","volume":"62","author":"Raderschall","year":"2002","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/sj.gt.3302967","article-title":"HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation","volume":"14","author":"Saydam","year":"2007","journal-title":"Gene Ther"},{"key":"B39","first-page":"7377","article-title":"Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity","volume":"63","author":"Russell","year":"2003","journal-title":"Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.ijrobp.2009.03.018","article-title":"Rad51 protein expression and survival in patients with glioblastoma multiforme","volume":"74","author":"Welsh","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1091\/mbc.e02-08-0454","article-title":"STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA","volume":"14","author":"Benitah","year":"2003","journal-title":"Mol Biol Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"6012642","DOI":"10.1155\/2016\/6012642","article-title":"Modulation of RhoA GTPase activity sensitizes human cervix carcinoma cells to \u03b3-radiation by attenuating DNA repair pathways. Oxid Med Cell Longev.","volume":"2016","author":"Osaki","year":"2016"},{"key":"B43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.prro.2016.03.007","article-title":"Radiation therapy for glioblastoma: executive summary of an American society for radiation oncology evidence-based clinical practice guideline","volume":"6","author":"Cabrera","year":"2016","journal-title":"Pract Radiat Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01498\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T23:46:17Z","timestamp":1578959177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01498\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":43,"alternative-id":["10.3389\/fonc.2019.01498"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.01498","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"article-number":"1498"}}